Area of research
Immunology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Inflammatory Bowel Disease, Spondyloarthritis Studies and Treatments, and Pharmaceutical studies and practices.
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones
Improving Diversity in a Novel Psoriasis Study
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study
Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results
Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn’s Disease
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease
Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Golimumab in Children With Moderately to Severely Active Ulcerative Colitis
Subcutaneous Golimumab in Pediatric Ulcerative Colitis
Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up